Yingke PE, an investment firm with nearly 50 billion yuan ($7.8 billion) in total assets, has announced the final close for its third US dollar-denominated fund, which will invest in biomedicine startups.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
